Syndetics cover image
Image from Syndetics

Pediatric psychopharmacology for primary care / Mark A. Riddle ; contributing editors, Jane Meschan Foy [and seven others].

By: Contributor(s): Material type: TextTextPublisher: Elk Grove Village, Illinois : American Academy of Pediatrics, 2016Copyright date: ©2016Description: 1 online resource (230 pages)Content type:
  • text
Media type:
  • computer
Carrier type:
  • online resource
ISBN:
  • 9781581109962 (e-book)
Subject(s): Genre/Form: Additional physical formats: Print version:: Pediatric psychopharmacology for primary care.DDC classification:
  • 618.928918 23
LOC classification:
  • RJ504.7 .R53 2016
Online resources:
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Call number Status Date due Barcode Item holds
Ebrary Online Books Ebrary Online Books Colombo Available CBEBK900020
Ebrary Online Books Ebrary Online Books Jaffna Available JFEBK900020
Ebrary Online Books Ebrary Online Books Kandy Available KDEBK900020
Total holds: 0

Enhanced descriptions from Syndetics:

Confidently prescribe, monitor, and manage medications for childhood mental health disorders. This game-changing resource from the American Academy of Pediatrics (AAP) arms you with a unique strategic approach - plus practice-tested, condition-specific treatment recommendations. Obtain clear guidance on dosing, monitoring, and potential adverse reactions of psychotropic medications for treatment of common psychiatric disorders and mental health or behavioral problems in children and adolescents.

Free bonus digital tool! Get instant answers on specific conditions and medications from your desktop or mobile device!

Evidence-based conceptual framework
A clear, straightforward methodology - based on current research and clinical experience - defines discrete levels of psychotropic agents and spells out level-specific roles and responsibilities.

Group 1:Medications FDA-approved for youth for ADHD, anxiety, and depression - disorders for which pediatric primary care providers commonly initiate treatment and assume prescribing and monitoring responsibilities.
Administration and management information for each drug agent includes: Rationale for use Evidence supporting efficacy and safety Initial dosing and subsequent adjustments Measuring therapeutic success When to consult or refer Group 2: Medications FDA-approved for youth, typically prescribed by specialists but often monitored in the primary care setting : antipsychotics, mood stabilizers, antidepressants, anxiolytics, and sleep aids. To support primary care clinician's collaborative role, usage rationales, efficacy data, and adverse effect profiles are specified for all of these agents.

Group 3: Medications not FDA-approved for youth that primary care clinicians will likely encounter. To support primary care clinician's collaborative role, efficacy data and adverse effect profiles are specified for these agents.

Proven, practice-focused guidance
Hands-on help spanning the therapeutic process: Assessing for common disorders Assessing for psychiatric comorbidities Identifying medication needs Informed consent Monitoring patient progress Managing side effects Managing multiple medications Stopping or changing medications

Includes bibliographical references and index.

Description based on online resource; title from PDF title page (ebrary, viewed January 08, 2016).

Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.

There are no comments on this title.

to post a comment.